DeVita, Seffrin Present Cancer Czar PlanTo Feinstein, Without Committee Sign-Off
Varmus, Branscomb Win Public Service Award From NSF; NCI Clarifies Plans For Large R01s
President’s Cancer Panel: NCI’s Approach “Paying Off,” Thompson Tells Cancer Panel
NCI Clarifies Plan For Review Of Epidemiologic Research
Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial
Oncology Management: US Oncology To Conduct Up To 5 Studies Of PG-TXL In Colorectal, Lung Cancers
Deals & Collaborations: UAB To Evaluate Firm’s Prostate Cancer Treatment
Emerging Technologies: Company To Expand Program Studying Polymer Platinates
Trending Stories
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest
- In the Headlines: MD Anderson’s Pisters on doing “something gigantic for pediatric cancer”
- As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater - Scaling excellence: How City of Hope is transforming cancer care delivery
